Surface Oncology Inc.

The momentum for this stock is not very good. Surface Oncology Inc. is not a good value stock. Surface Oncology Inc. is not a good growth stock. Surface Oncology Inc. is not very popular among insiders. Surface Oncology Inc. is a good stock to invest in, but there are better stocks to choose.
Log in to see more information.
Surface Oncology, Inc. is a clinical-stage immuno-oncology company, which focuses on biological path...

News

Coherus Biosciences completes Surface Oncology acquisition
Coherus Biosciences completes Surface Oncology acquisition

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Coherus Biosciences completes Surface Oncology acquisition
Coherus Biosciences completes Surface Oncology acquisition

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Surface Oncology Announces ISS and Glass Lewis Both Recommend Stockholders Vote  FOR  the Proposed Merger with Coherus BioSciences
Surface Oncology Announces ISS and Glass Lewis Both Recommend Stockholders Vote FOR the Proposed Merger with Coherus BioSciences

Globe Newswire Urges Stockholders to Vote Promptly to Ensure Their Shares are Represented at the September 7th Special MeetingCAMBRIDGE, Mass., Aug. 31, 2023 (GLOBE NEWSWIRE) -- Surface Oncology, Inc. (Nasdaq...\n more…

Financial Comparison: Surface Oncology (NASDAQ:SURF) vs. Vigil Neuroscience (NASDAQ:VIGL)
Financial Comparison: Surface Oncology (NASDAQ:SURF) vs. Vigil Neuroscience (NASDAQ:VIGL)

Ticker Report Vigil Neuroscience (NASDAQ:VIGL Get Free Report) and Surface Oncology (NASDAQ:SURF Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, ...\n more…

Surface Oncology (NASDAQ:SURF) versus Vigil Neuroscience (NASDAQ:VIGL) Head to Head Survey
Surface Oncology (NASDAQ:SURF) versus Vigil Neuroscience (NASDAQ:VIGL) Head to Head Survey

Zolmax Surface Oncology (NASDAQ:SURF Get Free Report) and Vigil Neuroscience (NASDAQ:VIGL Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, dividends, ...\n more…

Surface Oncology And Coherus BioSciences: Does A Buyout Equal A Good Deal?
Surface Oncology And Coherus BioSciences: Does A Buyout Equal A Good Deal?

SeekingAlpha Surface Oncology And Coherus BioSciences: Does A Buyout Equal A Good Deal...\n more…